Evidence-based clinical sciences are currently suffering from a paralyzing reproducibility crisis. From clinical psychology to cancer biology, recent meta-research indicates a rise in researchers’ failing to replicate studies published by their peers. This problem is not just limited to benchwork that happens in a lab; it also plagues translational research where the transformation from bench to bedside happens. Treatments, tests, and technologies are converted from simple lab experiments to FDA-approved devices and assays that affect hundreds of lives. Therefore, replicability is crucial to converting scientific breakthroughs into pragmatic remedies.